After getting beaten down for the better part of a year, Axon Enterprise NASDAQ: AXON scored a big win after its last earnings report. Shares surged by nearly 11% following the firm's May release, wit
Operational demonstrations and evaluation activities conducted with a leading defense force support the continued maturation of the EDGE ClearSky system amid the growing threat of FPV drones to maneuv
Axon raises its 2026 revenue outlook after Q1 sales surge 33.7%, fueled by strong demand for TASER 10, body cameras and AI offerings.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
ARM drops on smartphone concerns, memory stocks soar with continued chip shortages, and more
Axon Enterprise, Inc. (AXON) Q1 2026 Earnings Call Transcript
The headline numbers for Axon (AXON) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a

Axon Enterprise (AXON) Q1 Earnings Lag Estimates

06:25pm, Wednesday, 06'th May 2026
Axon Enterprise (AXON) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.41 per share a year ago.
TASER-maker Axon Enterprise raised its full-year revenue growth forecast on ​Wednesday, betting on strong demand ‌for its software products and security devices.
Axon Enterprise Inc. (NASDAQ:AXON) reported better-than-expected first-quarter results after Wednesday's closing bell.  Here's a look at the details inside the report.
SCOTTSDALE, Ariz., May 6, 2026 /PRNewswire/ -- Software & Services revenue grows 35% to $355 million; AI products up over 700% year over year Counter-drone product revenue up over 300% year over year
Live Updates The analyst who called NVIDIA in 2010 just named his top 10 AI stocksThis analyst's 2025 picks are up 106% on average. He just named his top 10 stocks to buy in 2026. Get them here FREE.
AXON heads into Q1 earnings with strong TASER, body camera and software demand expected to fuel growth despite rising costs.
Tallmadge, Ohio, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. Axavive is not intended to diagnose, treat, cure, or prevent any disease
Get a deeper insight into the potential performance of Axon (AXON) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE